Article
High CXCL6 drives matrix expression and correlate with markers of poor outcome in IPF
medRxiv · 2021 · Bahudhanapati, H.; Tan, J.; Apel, R.-M.; Seeliger, B.; Li, X.; Chen, T.-Y.; Sullivan, D.; Sembrat, J.; Rojas, M.; Valenzi, E.; Lafyatis, R. A.; Jawale, C.; Biswas, P.; Tedrow, J.; Adams, T. S.; Kaminski, N.; Wuyts, W. A.; McDyer, J. F.; Alder, J. K.; Zhang, Y.; Nouraie, M.; Prasse, A.; Kass, D. J.
Key facts
| Title | High CXCL6 drives matrix expression and correlate with markers of poor outcome in IPF |
|---|---|
| First author | Bahudhanapati, H.; Tan, J.; Apel, R.-M.; Seeliger, B.; Li, X.; Chen, T.-Y.; Sullivan, D.; Sembrat, J.; Rojas, M.; Valenzi, E.; Lafyatis, R. A.; Jawale, C.; Biswas, P.; Tedrow, J.; Adams, T. S.; Kaminski, N.; Wuyts, W. A.; McDyer, J. F.; Alder, J. K.; Zhang, Y.; Nouraie, M.; Prasse, A.; Kass, D. J. |
| Journal | medRxiv |
| Published | Jun 22, 2021 |
| DOI | 10.1101/2021.06.22.449424 |
| Devices mentioned | K802418 |
| Product codes mentioned | KIS |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1